investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

M. James You

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Peter Aplan

Pre-clinical Studies of Therapy for Myelodysplastic Syndrome

Leukaemia

Hematology and hematologic malignancies

Christophe P Nicot

HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB

Leukaemia

Pathology Hematology and hematologic malignancies

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Pathology Hematology and hematologic malignancies

Hamid Band

Tyrosine Kinase Regulation Via Protein Degradation

Leukaemia

Pathology Hematology and hematologic malignancies

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Leukaemia

David A Williams

Rac proteins in hematopoietic cell survival and function

Leukaemia

Hematology and hematologic malignancies

Scott H Kaufmann

Regulation of Death Ligand-Induced Killing

Leukaemia

Pathology Hematology and hematologic malignancies

Alan Rein

Interactions of APOBEC3 Proteins with Murine Leukemia Viruses

Leukaemia

Pathology Hematology and hematologic malignancies